Related Experiment Video
Updated: May 27, 2025

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines
Published on: October 8, 2015
BRAF V600E in cancer: Exploring structural complexities, mutation profiles, and pathway dysregulation
Jayhind Bharti1, Priyadharshini Gogu1, Sarvesh Kumar Pandey2
1Drug Discovery Laboratory, School of Pharmacy, GITAM (Deemed to be) University, Hyderabad Campus, 502329, India.
The BRAFV600E mutation drives cancer by creating a hyperactive BRAF protein, leading to uncontrolled cell growth. Targeting the resulting dysregulated pathways offers therapeutic opportunities for BRAF-mutant cancers.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- BRAF mutations are common in cancer, with V600E being a dominant alteration.
- Understanding BRAF V600E's structural impact is key to cancer mechanism insights.
Purpose of the Study:
- To review BRAF mutation classes and their role in tumorigenesis.
- To elucidate the impact of BRAFV600E on cellular signaling pathways.
- To highlight therapeutic strategies targeting BRAF-driven malignancies.
Main Methods:
- Review of scientific literature on BRAF mutations and associated signaling pathways.
- Analysis of structural differences between wild-type BRAF and BRAFV600E.
- Discussion of dysregulated pathways including MAPK/ERK, PI3K/AKT/mTOR, TP53, DDR, and WNT/β-Catenin.
Main Results:
- BRAFV600E mutation leads to a constitutively active kinase domain, promoting cancer hallmarks.
- BRAF mutations are classified into three distinct groups based on genetic alterations.
- Dysregulated signaling pathways are critical drivers of tumorigenesis and progression in BRAF-mutant cancers.
Conclusions:
- BRAF dysregulation is central to cancer development and progression.
- Targeting dysregulated pathways in BRAF-mutant cancers holds significant therapeutic potential.
- Further research into BRAF-driven malignancies can lead to improved treatment strategies.
More Related Videos
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...